Patient-centred outcomes are significantly modified by long-term home noninvasive ventilation (NIV), but a short, self-administered, specific tool for routine clinical assessment is lacking. The aim of this study was to develop and validate the S3-NIV questionnaire, a short questionnaire to measure respiratorysymptoms,sleep quality and NIV-relatedside effects. Patients with stable disease who were under long-term home NIV were recruited from three outpatient NIV services. Questionnaire development consisted of a selection of core items for analysis, followed by item reduction, validation and test–retest reliability. 338 patients completed a 22-item questionnaire. 11 items were removed because of non-scalability (n=2), redundancy (n=8) and lack of fit (n=1). The final version of the S3-NIV questionnaire consisted of 11 items covering two dimensions: “respiratory symptoms” (Cronbach's α=0.84) and “sleep & NIV-related side effects” (Cronbach's α=0.77). Convergent validity was high between the “respiratory symptoms” subscale of the S3-NIV questionnaire and the St George's Respiratory Questionnaire (rho= −0.76, p<0.001), and between the “sleep & NIV-related side effects” subscale and the Quebec Sleep Questionnaire (rho=0.51, p<0.001). The S3-NIV questionnaire had good test–retest reliability after 4 weeks (intraclass correlation coefficient=0.72). The S3-NIV questionnaire is a short, valid and repeatable self-completed tool for the routine clinical assessment of patients undergoing home NIV.
No takes yet. Share an insight, caveat, or question.
Dupuis‐Lozeron et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: